Mapping hepatitis C virus types in newly diagnosed patients
Part of Digestive system, Infections clinical trials.
This study looks at the specific type (genotype and subtype) of hepatitis C virus in people who are newly diagnosed. It helps doctors understand which strains are circulating so they can choose the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been newly diagnosed with hepatitis C (have antibodies to the virus).
- You have an active infection, meaning the virus is still found in your blood.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is evaluating a new blood test (Accupower HCV) to measure the amount of hepatitis C virus in your blood. If you have or may have hepatitis C, this test may help show how well your treatment is working.
This study looks at a step-by-step process to screen for hepatitis C, treat it, and help people clear the virus. If you meet the basic requirements, joining could help ensure you get evaluated and, if eligible, treated in a structured way.
This study looks for substances in your blood and immune system that could help doctors find liver cancer earlier. It is for people with liver cancer caused by chronic liver problems like hepatitis C, cirrhosis, or scarring.
This study looks at women with chronic hepatitis B or C to understand their current health status. It may help researchers find better ways to support patients like you.
This study looks for causes of acute hepatitis that doctors cannot explain yet. If you have symptoms of hepatitis but standard tests don't show the reason, this trial may help find new causes.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
Hear when a new Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.